← All stories
Markets
Definium Therapeutics to Participate at Upcoming Investor Conferences and Events
NEW YORK — Definium Therapeutics, Inc. (Nasdaq: DFTX) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurol…
Covered by 1 outlet
All coverage · 1 article